Adverse effects of the antimalaria drug, mefloquine: due to primary liver damage with secondary thyroid involvement?
<p>Abstract</p> <p>Background</p> <p>Mefloquine is a clinically important antimalaria drug, which is often not well tolerated. We critically reviewed 516 published case reports of mefloquine adverse effects, to clarify the phenomenology of the harms associated with mefl...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2002-03-01
|
| Series: | BMC Public Health |
| Online Access: | http://www.biomedcentral.com/1471-2458/2/6 |